Market Segmentation for C Reactive Protein Testing
The C Reactive Protein Testing Market can be segmented by assay type, application, and end user. By assay type, high-sensitivity CRP (hs-CRP) tests are growing quickly, driven by their value in early cardiovascular risk detection. Standard CRP assays remain widely used for infection and inflammation diagnosis.
By application, cardiovascular disease testing leads the market, followed by sepsis and arthritis monitoring. End-user segmentation shows hospitals and diagnostic laboratories as dominant, with clinics and homecare settings gaining ground due to point-of-care innovations. This diverse segmentation supports tailored product strategies and targeted growth in multiple sub-markets.
4 Views